Roscovitine is primarily utilized in research settings to study cell cycle regulation and apoptosis due to its ability to inhibit cyclin-dependent kinases (CDKs). It has shown potential in cancer therapy by inducing cell cycle arrest and promoting apoptosis in tumor cells. Additionally, it is being explored for its neuroprotective effects in neurodegenerative diseases and its role in reducing inflammation in various conditions. Roscovitine is also investigated for its antiviral properties, particularly in inhibiting viral replication. Its applications extend to studying cellular processes and developing targeted therapies for diseases involving CDK dysregulation.